Longboard Pharmaceuticals, Inc. Common Stock

LBPH

Market cap $2.34B

Delisted

LBPH was delisted on the 29th of November, 2024.

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	CAM 1 Cormorant Asset Management Boston, Massachusetts	$11.1M	–	–	–
2	2 T. Rowe Price Associates Baltimore, Maryland	$9.8M	-$1.77M	-260,674	-11%
3	3 Fidelity Investments Boston, Massachusetts	$7.34M	-$1.18M	-173,238	-10%
4	FCM 4 Farallon Capital Management San Francisco, California	$3.92M	–	–	–
5	5 Vanguard Group Malvern, Pennsylvania	$1.48M	+$887K	+130,400	+75%
6	6 Millennium Management New York	$1.09M	+$1.53M	+225,557	New
7	7 Citigroup New York	$968K	+$1.36M	+200,000	New
8	O 8 OrbiMed New York	$554K	–	–	–
9	BCM 9 Bridgeway Capital Management Houston, Texas	$339K	–	–	–
10	10 Alyeska Investment Group Chicago, Illinois	$305K	–	–	–
11	11 TD Asset Management Toronto, Ontario, Canada	$246K	-$43.7K	-6,425	-11%
12	IHAM 12 Integral Health Asset Management New York	$146K	–	–	–
13	13 Bank of America Charlotte, North Carolina	$115K	+$50.7K	+7,453	+46%
14	LCM 14 Laurion Capital Management New York	$101K	–	–	–
15	V 15 Veritable Wilmington, Delaware	$100K	–	–	–
16	16 BlackRock New York	$89K	+$3.2K	+470	+3%
17	17 Geode Capital Management Boston, Massachusetts	$73K	–	–	–
18	TRCT 18 Tower Research Capital (TRC) New York	$13K	+$13.8K	+2,034	+270%
19	MIFH 19 Migdal Insurance & Financial Holdings Petach Tikva, Israel	$5K	-$4.49K	-660	-38%
20	ECM 20 ExodusPoint Capital Management New York	–	-$107K	-12,073	Closed
21	21 UBS Group Zurich, Switzerland	–	-$13K	-1,430	Closed
22	22 Morgan Stanley New York	–	+$7	+1	New